Partner Certification & Solutions Catalog


Glide 5.7.111

The widespread use of combinatorial chemistry and high-throughput screening (HTS) in the pharmaceutical and biotechnology industries means that large numbers of compounds can now routinely be investigated for biological activity. However, screening large chemical libraries remains an expensive and time-consuming process, with significant rates of both false positives and false negatives.
High-speed computational methods can now enrich the fraction of suitable lead candidates in a chemical database, thereby creating the potential to greatly enhance productivity and dramatically reduce drug development costs. With an ever increasing number of drug discovery projects having access to high-resolution crystal structures of their targets, high-performance ligand-receptor docking is the clear computational strategy of choice to augment and accelerate structure-based drug design.

							
							
							
							
						
  • Category Engineering
  • Highlights
  • Platform SLED 11
  • Hardware Architecture x86-64
  • Certification SUSE Ready
  • Platform SLED 11
  • Hardware Architecture x86
  • Certification SUSE Ready
  • Platform SLES 11
  • Hardware Architecture x86-64
  • Certification SUSE Ready
  • Platform SLES 11
  • Hardware Architecture x86
  • Certification SUSE Ready

Other Versions

Glide 2022-2

  • Platform SLES 15, SLES 12
  • Hardware Architecture x86-64
  • Certification SUSE Ready
  • Highlights

Glide 2019-2

  • Platform SLED 15, SLES 15, SLED 12, SLES 12
  • Hardware Architecture x86-64
  • Certification SUSE Ready
  • Highlights

Glide 7.1

  • Platform SLED 12, SLES 12, SLED 11, SLES 11
  • Hardware Architecture x86-64
  • Certification SUSE Ready
  • Highlights

Glide 6.9

  • Platform SLED 12, SLES 12, SLED 11, SLES 11
  • Hardware Architecture x86-64
  • Certification SUSE Ready
  • Highlights

Glide 5.8

  • Platform SLED 11, SLES 11
  • Hardware Architecture x86-64, x86
  • Certification SUSE Ready
  • Highlights